当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析

博瑞医药

(688166)

  

流通市值:282.38亿  总市值:282.38亿
流通股本:4.23亿   总股本:4.23亿

博瑞医药(688166)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.10亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益290158.34万元,未分配利润97695.46万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产653505.19万元,负债363346.84万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入324,934,750.41,223,640,129.98874,249,705.24537,438,662.14
营业总成本329,340,975.821,204,341,010.5859,671,361.36549,542,369.7
其他经营收益
营业利润-3,688,657.714,664,116.0622,773,286.49-4,822,123.74
利润总额-3,476,899.6713,908,830.6622,414,798.66-5,021,225.35
净利润9,501,405.0436,954,239.1831,386,524.751,657,076.47
每股收益
其他综合收益-327,24836,676,515.56-2,579,713.14-2,579,713.14
综合收益总额9,174,157.0473,630,754.7428,806,811.61-922,636.67
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,306,642,462.431,788,502,174.91,466,597,706.531,543,927,667.97
非流动资产:
非流动资产合计4,228,409,414.124,036,339,503.613,893,472,334.773,839,866,910.55
资产总计6,535,051,876.555,824,841,678.515,360,070,041.35,383,794,578.52
流动负债:
流动负债合计991,267,743.871,280,306,196.281,167,050,820.961,157,002,452.45
非流动负债:
非流动负债合计2,642,200,687.261,698,359,977.141,661,300,790.681,640,625,190.99
负债合计3,633,468,431.132,978,666,173.422,828,351,611.642,797,627,643.44
所有者权益(或股东权益):
归属于母公司股东权益合计2,530,324,219.572,521,166,775.022,448,042,214.542,474,316,681.22
股东权益合计2,901,583,445.422,846,175,505.092,531,718,429.662,586,166,935.08
负债和股东权益合计6,535,051,876.555,824,841,678.515,360,070,041.35,383,794,578.52
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计248,014,327.231,254,084,109.38822,177,913.94562,391,959.6
经营活动现金流出小计359,279,019.5928,893,297.87723,223,052.13448,779,178.59
经营活动产生的现金流量净额-111,264,692.27325,190,811.5198,954,861.81113,612,781.01
投资活动产生的现金流量:
投资活动现金流入小计15,000,00090,808,375.8746,724,294.4246,722,764.42
投资活动现金流出小计160,715,625.93713,352,924.1599,293,366.52434,025,408.32
投资活动产生的现金流量净额-145,715,625.93-622,544,548.23-552,569,072.1-387,302,643.9
筹资活动产生的现金流量:
筹资活动现金流入小计1,208,539,613.921,539,848,100.82965,002,925.81748,699,300
筹资活动现金流出小计517,447,408.661,042,195,618.6671,336,996.93504,588,160.26
筹资活动产生的现金流量净额691,092,205.26497,652,482.22293,665,928.88244,111,139.74
汇率变动对现金及现金等价物的影响-2,267,044.22662,598.026,062,765.146,309,982.47
现金及现金等价物净增加额431,844,842.84200,961,343.52-153,885,516.27-23,268,740.68
期末现金及现金等价物余额1,357,400,016.88955,063,274.47600,216,414.68730,833,190.27
补充资料:
现金及现金等价物的净增加额-200,961,343.52--23,268,740.68
TOP↑